14/10/2008
Molecular diagnostics concern Tepnel Life Sciences has added the iScan Rapid Reader to its range of products and services.
Manchester-based Tepnel says the Rapid Reader is part of the US genetic research group’s iScan System. This is a ‘next-generation’ scanner, aiding researchers conducting genetic variation studies, developed by US genetic group Illumina.
AIM-quoted Tepnel, which has had its ups and downs over the years, says iScan, whose Illumina platform can generate up to ‘225 million genotypes a day’, adds a new string to Tepnel’s bow. The company, which made £1.4 million in the six months to June, says it can now offer customers ‘a broad portfolio of innovative genetic analysis assays’.
Shares in Tepnel have risen from 5.75p two years ago to 13.5p today, valuing the company at £31.5 mllion.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Related Articles:
|
| 16/05/2008
|
| 16/05/2008
|
| 15/05/2008
|
| 14/05/2008
|
| 12/05/2008
|
| AIM | £26.26m |
11.25p
|
-0.75p
|
|
| Other company articles: |
| 14/10/2008 |
| 17/12/2007 |
| 05/09/2007 |
| 15/07/2005 |
| 27/03/2002 |
Compare Over 1100 UK Saving Accounts
Arrow1066 provides a savings tool and guide to compare over 1100 UK bank, building society & online savings accounts. Compare interest rates & see how much extra you could earn.
